Products
Company credited for technology, KyungDong Pharm
View Product
Byaflu Cap.75mg
- Brand name Byaflu Cap.75mg
- Category Antiviral
- Active Ingredient Oseltamivir Phosphate
- Rx/OTC Rx
- Active Ingredient
Oseltamivir Phosphate 98.5mg (as Oseltamivir 75mg)
- Indication
1. Treatment Of Influenza A and B virus infection in patients 2 weeks of age and older who have been symptomatic for no more than 48 hours.
2. Prophylaxis of influenza A and B virus in patients 1 year and older. (Byaflu is not a substitute for influenza vaccination.)
- Dosage & Administration
1. Treatment of influenza A and B virus infection : Treatment should be initiated as soon as possible within the first two days of onset of symptoms of influenza. BYAFLU may be taken with or without food; however, tolerability may be enhanced if BYAFLU is taken with food.
1) Adults, and adolescents 13 years and over : The recommended oral dose is 75 mg oseltamivir twice daily for 5 days. The powder for oral suspension (6 mg/ml) is the preferred product for paediatric and adult patients who have
- Drug Class
Antiviral agent of Influenza A and B virus
Oseltamivir Phosphate 98.5mg (as Oseltamivir 75mg)
- Indication
1. Treatment Of Influenza A and B virus infection in patients 2 weeks of age and older who have been symptomatic for no more than 48 hours.
2. Prophylaxis of influenza A and B virus in patients 1 year and older. (Byaflu is not a substitute for influenza vaccination.)
- Dosage & Administration
1. Treatment of influenza A and B virus infection : Treatment should be initiated as soon as possible within the first two days of onset of symptoms of influenza. BYAFLU may be taken with or without food; however, tolerability may be enhanced if BYAFLU is taken with food.
1) Adults, and adolescents 13 years and over : The recommended oral dose is 75 mg oseltamivir twice daily for 5 days. The powder for oral suspension (6 mg/ml) is the preferred product for paediatric and adult patients who have
- Drug Class
Antiviral agent of Influenza A and B virus